IL1B and Insulin resistance: Attenuation of TNFα/IL-1β/CCL2-mediated inflammation in metabolic organs has been shown to improve insulin resistance [53,54,55], consistent with the observed reduction of fasting insulin and HOMA-IR in KrO-treated mice.